These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7378710)

  • 1. Re-assessment of normalization between fractionated and continuous radiotherapy for the CRE and TDF equations.
    Orton CG
    Br J Radiol; 1980 Apr; 53(628):374-5. PubMed ID: 7378710
    [No Abstract]   [Full Text] [Related]  

  • 2. The relevance of the TDF and CRE concepts in combined radiation treatment of early cancer of the cervix uteri.
    Urbański K; Maciejewski B; Skołyszewski J
    Radiobiol Radiother (Berl); 1986; 27(1):17-23. PubMed ID: 3704123
    [No Abstract]   [Full Text] [Related]  

  • 3. Fractionated high dose rate versus low dose rate cervix cancer regimens.
    Orton CG
    Br J Radiol; 1991 Dec; 64(768):1165-6. PubMed ID: 1773281
    [No Abstract]   [Full Text] [Related]  

  • 4. Gap corrections for brachytherapy.
    Supe SJ
    Strahlentherapie; 1979 Dec; 155(12):833-40. PubMed ID: 516107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of the TDF factor in planning the combined radiation therapy of cervical cancer and the assessment of complications].
    Kostromina KN; Fadeeva MA
    Med Radiol (Mosk); 1980 Jun; 25(6):57-63. PubMed ID: 7392836
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of radiotherapy of malignant neoplasms with fractionated doses].
    Zholkiver KI; Karibdzhanova ZB; Balmukhanov SB
    Med Radiol (Mosk); 1973 Jan; 18(1):73-81. PubMed ID: 4200135
    [No Abstract]   [Full Text] [Related]  

  • 7. [Method of calculating TDF biological equivalent for optimal treatment dose in fractionated intracavitary irradiation of carcinoma of the uterine cervix].
    Kutsutani-Nakamura Y; Furukawa S; Tabushi K; Akanuma A; Kubota S; Nakano T; Morita S; Fukuhisa K; Arai T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jul; 56(8):570-4. PubMed ID: 8797348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between central recurrence and time-dose factors in patients with carcinoma of uterine cervix after radiotherapy].
    Gao JZ
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):394-7. PubMed ID: 2515955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of fractionated dose schedules in the intracavitary gamma-therapy of cervical cancer].
    Vishnevskaia EE; Minenko VF
    Med Radiol (Mosk); 1982 Jun; 27(6):7-11. PubMed ID: 7109868
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical value of the Nominal Standard Dose (NSD) and Time-Dose Factor (TDF) in the evaluation of probability of cure and risk of complications in patients with cervical cancer treated with radium].
    Rattka P; Maciejewski B
    Pol Przegl Radiol Med Nukl; 1982; 46(5-6):281-6. PubMed ID: 7170254
    [No Abstract]   [Full Text] [Related]  

  • 11. [The TDF (time-dose-fractionation) model in brachytherapy].
    Fadeeva MA; Datsenko VS; Klepper LIa; Podliashchuk EL; Ustinova VF
    Med Radiol (Mosk); 1988 Oct; 33(10):25-30. PubMed ID: 3185185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A graphical method to simplify the application of the linear-quadratic dose-effect equation to fractionated radiotherapy.
    Dale RG
    Br J Radiol; 1986 Nov; 59(707):1111-5. PubMed ID: 3790899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
    Gupta T
    Radiother Oncol; 2004 Apr; 71(1):117-8; author reply 118. PubMed ID: 15066305
    [No Abstract]   [Full Text] [Related]  

  • 14. The precision of dose calculation and the activity distribution of Selectron sources.
    Wilkinson JM
    Br J Radiol; 1982 Oct; 55(658):778-9. PubMed ID: 7127031
    [No Abstract]   [Full Text] [Related]  

  • 15. The dose time relationship in the radiotherapy of carcinoma of the cervix--application of CRE formalism.
    Supe SS; Swamy K; Viswanathan N; Kumar MU; Anantha N
    Indian J Cancer; 1992 Sep; 29(3):148-58. PubMed ID: 1292998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRE calculations for different combined radiation therapy schemes of uterine cervical carcinoma.
    Väyrynen T; Kiviniitty K; Kauppila A
    Strahlentherapie; 1981 Jun; 157(6):396-9. PubMed ID: 7256808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Point.
    Alektiar KM
    Brachytherapy; 2002; 1(4):191-2. PubMed ID: 15062165
    [No Abstract]   [Full Text] [Related]  

  • 18. Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Counterpoint.
    Mundt AJ; Roeske JC
    Brachytherapy; 2002; 1(4):192-4. PubMed ID: 15062166
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of high activity cobalt 60 sources for intracavitary and surface mould therapy.
    Joslin CA; Smith CW
    Proc R Soc Med; 1970 Oct; 63(10):1029-34. PubMed ID: 5483502
    [No Abstract]   [Full Text] [Related]  

  • 20. Volume correction factor in time dose relationships in brachytherapy.
    Supe SJ; Sasane JB; Gupta MK
    Strahlenther Onkol; 1987 May; 163(5):309-13. PubMed ID: 3589957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.